Morgan Stanley’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.6M | Sell |
1,793,471
-1,143,996
| -39% | -$15M | ﹤0.01% | 2638 |
|
|
2025
Q1 | $42.2M | Buy |
2,937,467
+1,012,958
| +53% | +$14.6M | ﹤0.01% | 1959 |
|
|
2024
Q4 | $32.2M | Buy |
1,924,509
+544,858
| +39% | +$9.13M | ﹤0.01% | 2263 |
|
|
2024
Q3 | $22.1M | Sell |
1,379,651
-670,741
| -33% | -$10.7M | ﹤0.01% | 2702 |
|
|
2024
Q2 | $18.5M | Sell |
2,050,392
-86,973
| -4% | -$785K | ﹤0.01% | 2749 |
|
|
2024
Q1 | $24.2M | Sell |
2,137,365
-290,735
| -12% | -$3.29M | ﹤0.01% | 2497 |
|
|
2023
Q4 | $19.3M | Buy |
2,428,100
+1,470,149
| +153% | +$11.7M | ﹤0.01% | 3375 |
|
|
2023
Q3 | $6.2M | Buy |
957,951
+133,322
| +16% | +$863K | ﹤0.01% | 3561 |
|
|
2023
Q2 | $5.1M | Buy |
824,629
+80,722
| +11% | +$500K | ﹤0.01% | 3766 |
|
|
2023
Q1 | $2.86M | Buy |
743,907
+428,772
| +136% | +$1.65M | ﹤0.01% | 4218 |
|
|
2022
Q4 | $977K | Buy |
315,135
+298,641
| +1,811% | +$926K | ﹤0.01% | 4886 |
|
|
2022
Q3 | $67K | Sell |
16,494
-23,770
| -59% | -$96.6K | ﹤0.01% | 6264 |
|
|
2022
Q2 | $196K | Buy |
40,264
+18,652
| +86% | +$90.8K | ﹤0.01% | 5911 |
|
|
2022
Q1 | $194K | Buy |
21,612
+7,527
| +53% | +$67.6K | ﹤0.01% | 5938 |
|
|
2021
Q4 | $158K | Buy |
14,085
+6,455
| +85% | +$72.4K | ﹤0.01% | 6182 |
|
|
2021
Q3 | $128K | Buy |
+7,630
| New | +$128K | ﹤0.01% | 6223 |
|